ACHV
ACHV
NASDAQ · Biotechnology

Achieve Life Sciences Inc

$6.32
+0.03 (+0.48%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 17 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +404.6% upside
Low Target $22.93
Average Target $31.89
High Target $41.27
Current Price $6.32
Current
$6.32
Target
$31.89
$22.93 $31.89 avg $41.27
Scenario Analysis
Bear Case
$22.93
262.8%
Low target
Base Case
$31.89
+404.6%
Avg target
Bull Case
$41.27
+553.0%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$8.64
-26.9% from high
52-Week Low
$2.62
+141.2% from low
Target vs 52W High
$31.89
+269.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.6%
AMGN
Amgen Inc
Hold 42 43% $190.87 -58.2%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +114.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -17.6%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
MRNA
Moderna Inc
Hold 31 32% $149.45 -30.6%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -50.5%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -31.6%